Shakir Al-Fatlawi, Ali
Snoubar, Yaser
Adel Yosef, Noor
Article History
Received: 16 November 2024
Accepted: 7 January 2026
First Online: 16 January 2026
Competing interests
: The authors declare no competing interests.
: The study protocol was reviewed and approved by the Iraqi Ministry of Health Institutional Review Board (IRB), approval ID 4370/4/4/2024 – No. 4246/21, with official approval dated April 4, 2024. The study complied with all relevant ethical guidelines and regulations issued by national and institutional authorities.
: Verbal informed consent was obtained from all participants prior to their involvement in the study, during the data-collection period between April 5 and May 15, 2024. The IRB approved the use of verbal consent and granted a waiver of written documentation due to the study’s minimal risk and anonymized survey design. Participants were informed about the study purpose, procedures, voluntary nature of participation, the right to withdraw at any time without penalty, and data confidentiality protections.